BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 20831478)

  • 21. Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT.
    Epelbaum R; Frenkel A; Haddad R; Sikorski N; Strauss LG; Israel O; Dimitrakopoulou-Strauss A
    J Nucl Med; 2013 Jan; 54(1):12-8. PubMed ID: 23166388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
    Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N
    Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of animal handling on the results of 18F-FDG PET studies in mice.
    Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
    J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment.
    Wilson GD; Thibodeau BJ; Fortier LE; Pruetz BL; Galoforo S; Baschnagel AM; Chunta J; Oliver Wong CY; Yan D; Marples B; Huang J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):620-7. PubMed ID: 25304950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron Emission Tomography (PET) and Pharmacokinetics: Classical Blood Sampling Versus Image-Derived Analysis of [18F]FAZA and [18F]FDG in a Murine Tumor Bearing Model.
    Jans HS; Yang XH; Brocks DR; Kumar P; Wuest M; Wiebe LI
    J Pharm Pharm Sci; 2018; 21(1s):32s-47s. PubMed ID: 29702045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT.
    Gheysens O; Postnov A; Deroose CM; Vandermeulen C; de Hoon J; Declercq R; Dennie J; Mixson L; De Lepeleire I; Van Laere K; Klimas M; Chakravarthy MV
    J Nucl Med; 2015 Oct; 56(10):1520-6. PubMed ID: 26229142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas.
    Rusten E; Rødal J; Revheim ME; Skretting A; Bruland OS; Malinen E
    Acta Oncol; 2013 Aug; 52(6):1160-7. PubMed ID: 23198721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics.
    Strauss LG; Dimitrakopoulou-Strauss A; Haberkorn U
    J Nucl Med; 2003 Dec; 44(12):1933-9. PubMed ID: 14660719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice.
    Massollo M; Marini C; Brignone M; Emionite L; Salani B; Riondato M; Capitanio S; Fiz F; Democrito A; Amaro A; Morbelli S; Piana M; Maggi D; Cilli M; Pfeffer U; Sambuceti G
    J Nucl Med; 2013 Feb; 54(2):259-66. PubMed ID: 23287574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model.
    Guo N; Lang L; Gao H; Niu G; Kiesewetter DO; Xie Q; Chen X
    Mol Imaging Biol; 2012 Dec; 14(6):743-52. PubMed ID: 22437879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
    Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
    J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability of dynamic 18F-FDG-PET data in breast cancer xenografts.
    Pitman KE; Rusten E; Kristian A; Malinen E
    Acta Oncol; 2015; 54(9):1399-407. PubMed ID: 26217987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.
    Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH
    J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer.
    Gutte H; Hansen AE; Larsen MM; Rahbek S; Henriksen ST; Johannesen HH; Ardenkjaer-Larsen J; Kristensen AT; Højgaard L; Kjær A
    J Nucl Med; 2015 Nov; 56(11):1786-92. PubMed ID: 26338899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
    Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C
    Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of using abbreviated scan protocols with population-based input functions for accurate kinetic modeling of [
    Sari H; Eriksson L; Mingels C; Alberts I; Casey ME; Afshar-Oromieh A; Conti M; Cumming P; Shi K; Rominger A
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):257-265. PubMed ID: 36192468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First results on kinetic modelling and parametric imaging of dynamic
    Sari H; Mingels C; Alberts I; Hu J; Buesser D; Shah V; Schepers R; Caluori P; Panin V; Conti M; Afshar-Oromieh A; Shi K; Eriksson L; Rominger A; Cumming P
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1997-2009. PubMed ID: 34981164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by
    van Berkel A; Vriens D; Visser EP; Janssen MJR; Gotthardt M; Hermus ARMM; Geus-Oei LF; Timmers HJLM
    J Nucl Med; 2019 Jun; 60(6):745-751. PubMed ID: 30413658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.